Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 18, 2014
Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance dataMatteo Zignol, Masoud Dara, Anna S Dean, et al.
Infectious Diseases of Poverty|July 20, 2020
Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort studyXu-Bin Zheng, Vinod K Diwan, Qi Zhao, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Detection of <i>Mycobacterium tuberculosis pncA</i> Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional SequencingMelisa J Willby, Maria Wijkander, Joshua Havumaki, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 7, 2009
Drug resistance and genotypic analysis of Mycobacterium tuberculosis strains from Thai tuberculosis patientsWattana Cheunoy, Melles Haile, Angkana Chaiprasert, et al.
The European Respiratory Journal|October 19, 2011
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in MinskAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2012
Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathioneJun Lu, Alexios Vlamis-Gardikas, Karuppasamy Kandasamy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Extensively drug-resistant tuberculosis: 2 years of surveillance in IranMohamad Reza Masjedi, Parissa Farnia, Setara Sorooch, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2009
Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrBAndrea Von Groll, Anandi Martin, Pontus Jureen, et al.
Pageof 11